The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Versatility of PRMT5-induced methylation in growth control and development
Open accessAbstract
Arginine methylation governs important cellular processes that impact growth and proliferation, as well as differentiation and development. Through their ability to catalyze symmetric or asymmetric methylation of histones and non-histone proteins, members of the protein arginine methyltransferase (PRMT) family regulate chromatin structure and expression of a wide spectrum of target genes. Unlike other PRMTs, PRMT5 works in concert with a variety of cellular proteins including ATP-dependent chromatin remodelers and co-repressors to induce epigenetic silencing. Recent work also implicates PRMT5 in the control of growth-promoting and pro-survival pathways, demonstrating its versatility as an enzyme involved in both epigenetic regulation of anti-cancer target genes and organelle biogenesis. These studies not only provide insight into the molecular mechanisms by which PRMT5 contributes to growth control, but also justify targeting PRMT5 therapeutically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Histone modifications in transcriptional regulation
Berger, S. L. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00279-4 · Cited by 1,220
Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination
Wang, Y., Wysocka, J., Sayegh, J., Lee, Y.-H., Perlin, J. R., Leonelli, L., Sonbuchner, L. S., McDonald, C. H., Cook, R. G., Dou, Y., et al. (2004) · Science · doi:10.1126/science.1101400 · Cited by 1,010
Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5
Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., & Ashkenazi, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80212-5 · Cited by 975
Database of p53 gene somatic mutations in human tumors and cell lines.
Hollstein, M. C., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sørlie, T., Hovig, E. J., Smith‐Sørensen, B., Montesano, R., & Harris, C. C. (1994) · Europe PMC (PubMed Central) · Cited by 858
Histone Deimination Antagonizes Arginine Methylation
Cuthbert, G. L., Daujat, S., Snowden, A. W., Erdjument-Bromage, H., Hagiwara, T., Yamada, M., Schneider, R., Gregory, P. D., Tempst, P., Bannister, A. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.08.020 · Cited by 839
Regulation of p53 activity through lysine methylation
Chuikov, S., Kurash, J. K., Wilson, J. R., Xiao, B., Justin, N., Ivanov, G. S., McKinney, K., Tempst, P., Prives, C., Gamblin, S. J., et al. (2004) · Nature · doi:10.1038/nature03117 · Cited by 816
JMJD6 Is a Histone Arginine Demethylase
Chang, B., Chen, Y., Zhao, Y., & Bruick, R. K. (2007) · Science · doi:10.1126/science.1145801 · Cited by 745
TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB
Schneider, P., Thome, M., Burns, K., Bodmer, J.-L., Hofmann, K., Kataoka, T., Holler, N., & Tschopp, J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80401-x · Cited by 696
Repression of p53 activity by Smyd2-mediated methylation
Huang, J., Perez-Burgos, L., Placek, B. J., Sengupta, R., Richter, M., Dorsey, J. A., Kubicek, S., Opravil, S., Jenuwein, T., & Berger, S. L. (2006) · Nature · doi:10.1038/nature05287 · Cited by 624
Pal, S., Vishwanath, S. N., Erdjument-Bromage, H., Tempst, P., & Sif, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9630-9645.2004 · Cited by 592
Self-citationAlt, J. R., Cleveland, J. L., Hannink, M., & Diehl, J. A. (2000) · Genes & Development · doi:10.1101/gad.854900 · Cited by 535
Zhao, Q., Rank, G., Tan, Y. T., Li, H., Moritz, R. L., Simpson, R. J., Cerruti, L., Curtis, D. J., Patel, D. J., Allis, C. D., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1568 · Cited by 535
RNA and Protein Interactions Modulated by Protein Arginine Methylation
Gary, J. D., & Clarke, S. (1998) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60825-9 · Cited by 500
Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494
Cycling to Cancer with Cyclin D1
Diehl, J. A. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.72 · Cited by 475
Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells
Ancelin, K., Lange, U. C., Hajkova, P., Schneider, R., Bannister, A. J., Kouzarides, T., & Surani, M. A. (2006) · Nature Cell Biology · doi:10.1038/ncb1413 · Cited by 464
Modulation of p53 Function by SET8-Mediated Methylation at Lysine 382
Shi, X., Kachirskaia, I., Yamaguchi, H., West, L. E., Wen, H., Wang, E. W., Dutta, S., Appella, E., & Gozani, O. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.012 · Cited by 462
Arginine methylation regulates the p53 response
Jansson, M., Durant, S. T., Cho, E.-C., Sheahan, S., Edelmann, M., Kessler, B., & La Thangue, N. B. (2008) · Nature Cell Biology · doi:10.1038/ncb1802 · Cited by 462
Jmjd6 Catalyses Lysyl-Hydroxylation of U2AF65, a Protein Associated with RNA Splicing
Webby, C. J., Wolf, A., Gromak, N., Dreger, M., Kramer, H., Kessler, B., Nielsen, M. L., Schmitz, C., Butler, D. S., Yates, J. R., et al. (2009) · Science · doi:10.1126/science.1175865 · Cited by 423
Tee, W.-W., Pardo, M., Theunissen, T. W., Yu, L., Choudhary, J. S., Hajkova, P., & Surani, M. A. (2010) · Genes & Development · doi:10.1101/gad.606110 · Cited by 356
Arginine methylation at a glance
Bedford, M. T. (2007) · Journal of Cell Science · doi:10.1242/jcs.019885 · Cited by 341
MBD2/NuRD and MBD3/NuRD, Two Distinct Complexes with Different Biochemical and Functional Properties
Le Guezennec, X., Vermeulen, M., Brinkman, A. B., Hoeijmakers, W. A. M., Cohen, A., Lasonder, E., & Stunnenberg, H. G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.843-851.2006 · Cited by 340
Small Molecule Regulators of Protein Arginine Methyltransferases
Cheng, D., Yadav, N., King, R. W., Swanson, M. S., Weinstein, E. J., & Bedford, M. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401853200 · Cited by 339
Vagin, V. V., Wohlschlegel, J., Qu, J., Jonsson, Z., Huang, X., Chuma, S., Girard, A., Sachidanandam, R., Hannon, G. J., & Aravin, A. A. (2009) · Genes & Development · doi:10.1101/gad.1814809 · Cited by 313
The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation
Lankat‐Buttgereit, B., & Göke, R. (2009) · Biology of the Cell · doi:10.1042/bc20080191 · Cited by 311
Pollack, B. P., Kotenko, S. V., He, W., Izotova, L. S., Barnoski, B. L., & Pestka, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31531 · Cited by 290
Low levels of miR‐92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma
Pal, S., Baiocchi, R. A., Byrd, J. C., Grever, M. R., Jacob, S. T., & Sif, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601794 · Cited by 282
Self-citationLiu, F., Zhao, X., Perna, F., Wang, L., Koppikar, P., Abdel-Wahab, O., Harr, M. W., Levine, R. L., Xu, H., Tefferi, A., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.020 · Cited by 273
Wang, L., Pal, S., & Sif, S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00923-08 · Cited by 259
Self-citationAggarwal, P., Vaites, L. P., Kim, J. K., Mellert, H., Gurung, B., Nakagawa, H., Herlyn, M., Hua, X., Rustgi, A. K., McMahon, S. B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.012 · Cited by 242
Hsu, J.-M., Chen, C.-T., Chou, C.-K., Kuo, H.-P., Li, L.-Y., Lin, C.-Y., Lee, H.-J., Wang, Y.-N., Liu, M., Liao, H.-W., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2158 · Cited by 236
Hou, Z., Peng, H., Ayyanathan, K., Yan, K.-P., Langer, E. M., Longmore, G. D., & Rauscher, F. J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01435-07 · Cited by 222
Advances in the understanding of haemoglobin switching
Sankaran, V. G., Xu, J., & Orkin, S. H. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08105.x · Cited by 214
PRMT5 is required for cell-cycle progression and p53 tumor suppressor function
Scoumanne, A., Zhang, J., & Chen, X. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp516 · Cited by 194
Deng, X., Gu, L., Liu, C., Lu, T., Lu, F., Lu, Z., Cui, P., Pei, Y., Wang, B., Hu, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009669107 · Cited by 191
Dacwag, C. S., Ohkawa, Y., Pal, S., Sif, S., & Imbalzano, A. N. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01528-06 · Cited by 190
Self-citationInterplay between chromatin remodelers and protein arginine methyltransferases
Pal, S., & Sif, S. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21180 · Cited by 173
Self-citationGuderian, G., Peter, C., Wiesner, J., Sickmann, A., Schulze-Osthoff, K., Fischer, U., & Grimmler, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.148486 · Cited by 162
Powers, M. A., Fay, M. M., Factor, R. E., Welm, A. L., & Ullman, K. S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0458 · Cited by 159
Ren, J., Wang, Y., Liang, Y., Zhang, Y., Bao, S., & Xu, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.103911 · Cited by 152
Teng, Y., Girvan, A. C., Casson, L. K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4206 · Cited by 152
Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins
Gonsalvez, G. B., Tian, L., Ospina, J. K., Boisvert, F., Lamond, A. I., & Matera, A. G. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200702147 · Cited by 151
Lacroix, M., Messaoudi, S. E., Rodier, G., Cam, A. L., Sardet, C., & Fabbrizio, E. (2008) · EMBO Reports · doi:10.1038/embor.2008.45 · Cited by 145
Jak2: normal function and role in hematopoietic disorders
Ihle, J. N., & Gilliland, D. G. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.009 · Cited by 143
Xu, Y., Wan, H., Zhao, X., Zhu, S., Zhou, Q., & Ding, S. (2011) · Stem Cells · doi:10.1002/stem.594 · Cited by 135
Kawaguchi, T., Kato, S., Otsuka, K., Watanabe, G., Kumabe, T., Tominaga, T., Yoshimoto, T., & Ishioka, C. (2005) · Oncogene · doi:10.1038/sj.onc.1208839 · Cited by 128
Eckert, D., Biermann, K., Nettersheim, D., Gillis, A., Steger, K., Jäck, H., Müller, A. M., Looijenga, L. H. J., & Schorle, H. (2008) · BMC Developmental Biology · doi:10.1186/1471-213x-8-106 · Cited by 124
Dacwag, C. S., Bedford, M. T., Sif, S., & Imbalzano, A. N. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00742-08 · Cited by 122
Self-citationThe Sm-Protein Methyltransferase, Dart5, Is Essential for Germ-Cell Specification and Maintenance
Gonsalvez, G. B., Rajendra, T. K., Tian, L., & Matera, A. G. (2006) · Current Biology · doi:10.1016/j.cub.2006.04.037 · Cited by 113
Davison, T. S., Yin, P., Nie, E., Kay, C. M., & Arrowsmith, C. H. (1998) · Oncogene · doi:10.1038/sj.onc.1202062 · Cited by 112
Role of pICLn in Methylation of Sm Proteins by PRMT5
Pesiridis, G. S., Diamond, E., & Duyne, G. D. V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.015578 · Cited by 109
Lomax, M. E., Barnes, D. M., Hupp, T. R., Picksley, S. M., & Camplejohn, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201974 · Cited by 100
Rank, G., Cerruti, L., Simpson, R. J., Moritz, R. L., Jane, S. M., & Zhao, Q. (2010) · Blood · doi:10.1182/blood-2009-10-251116 · Cited by 98
Control of the DNA Methylation System Component MBD2 by Protein Arginine Methylation
Tan, C. P., & Nakielny, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00473-06 · Cited by 97
PRMT5 regulates Golgi apparatus structure through methylation of the golgin GM130
Zhou, Z., Sun, X., Zou, Z., Sun, L., Zhang, T., Guo, S., Wen, Y., Liu, L., Wang, Y., Qin, J., et al. (2010) · Cell Research · doi:10.1038/cr.2010.56 · Cited by 88
Tanaka, H., Hoshikawa, Y., Oh‐hara, T., Koike, S., Naito, M., Noda, T., Arai, H., Tsuruo, T., & Fujita, N. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0197 · Cited by 86
Anne, J., Ollo, R., Ephrussi, A., & Mechler, B. M. (2007) · Development · doi:10.1242/dev.02687 · Cited by 78
Analysis of Jmjd6 Cellular Localization and Testing for Its Involvement in Histone Demethylation
Hahn, P., Wegener, I., Burrells, A., Böse, J., Wolf, A., Erck, C., Butler, D. S., Schofield, C. J., Böttger, A., & Lengeling, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013769 · Cited by 78
A Germ Cell-specific Gene, Prmt5, Works in Somatic Cell Reprogramming
Nagamatsu, G., Kosaka, T., Kawasumi, M., Kinoshita, T., Takubo, K., Akiyama, H., Sudo, T., Kobayashi, T., Oya, M., & Suda, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216390 · Cited by 77
Tabata, T., Kokura, K., ten Dijke, P., & Ishii, S. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01246.x · Cited by 66
Yang, M., Sun, J., Sun, X., Shen, Q., Gao, Z., & Yang, C. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000514 · Cited by 65
Mallappa, C., Hu, Y., Shamulailatpam, P., Tae, S., Sif, S., & Imbalzano, A. N. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq896 · Cited by 43
Self-citationPikman, Y., & Levine, R. L. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f0e20c · Cited by 8
Cited by
Histone Modifications and Cancer
Audia, J. E., & Campbell, R. M. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019521 · Cited by 1,024
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
Kryukov, G. V., Wilson, F. H., Ruth, J. R., Paulk, J., Tsherniak, A., Marlow, S. E., Vazquez, F., Weir, B. A., Fitzgerald, M. E., Tanaka, M., et al. (2016) · Science · doi:10.1126/science.aad5214 · Cited by 688
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Chan-Penebre, E., Kuplast, K. G., Majer, C. R., Boriack-Sjodin, P. A., Wigle, T. J., Johnston, L. D., Rioux, N., Munchhof, M. J., Jin, L., Jacques, S. L., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1810 · Cited by 569
The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
Stopa, N., Krebs, J. E., & Shechter, D. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1847-9 · Cited by 513
Pancreatic cancer organoids recapitulate disease and allow personalized drug screening
Driehuis, E., van Hoeck, A., Moore, K., Kolders, S., Francies, H. E., Gulersonmez, M. C., Stigter, E. C. A., Burgering, B., Geurts, V., Gracanin, A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911273116 · Cited by 459
Metadata
- Authors
- Karkhanis, V., Hu, Y.-J., Baiocchi, R. A., Imbalzano, A. N., & Sif, S.
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 36
- Issue
- 12
- Pages
- 633-641
- ISSN
- 0968-0004 (ISSN-L)
- OpenAlex
- W1993023587
- Cited by
- 280
- References
- 70
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.